Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on December 14, 2022. The filing discloses significant capital raising activities, including the commencement of a public offering of senior notes and the pricing of a registered direct offering of common stock.
Key Financial Metrics and Capital Structure
The filing details two major financing transactions announced on December 14, 2022:
- Senior Notes Offering: Commencement of a public offering of $100,000,000 aggregate principal amount of senior notes due 2027. The underwriters have been granted a 30-day option to purchase up to an additional $15,000,000.
- Common Stock Offering: Pricing of a registered direct offering of $25,000,000 of common stock to accredited investors at an offering price of $10.52 per share. The closing is anticipated on or about December 16, 2022.
The filing text does not provide specific values for revenue, profit, cash flow, operating margins, or existing debt levels outside of the new offerings and previously registered 8.625% Senior Notes due 2026.
Material Changes and Outlook
The primary material change is the expansion of the company's capital base through the issuance of new debt and equity. Management intends to use the proceeds from these offerings, though specific allocation details are referenced in the attached press releases rather than explicitly detailed in the main body of this 8-K. The company is conducting road show presentations to existing and potential securityholders regarding the Note Offering.
Risks and Contingencies
The filing includes a standard cautionary note regarding forward-looking statements. These statements are subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from expectations. The company explicitly states it undertakes no obligation to update these forward-looking statements to reflect future events or unanticipated circumstances.
Investor Verification Checklist
- Verify the final closing date and total proceeds of the Common Stock Offering (anticipated December 16, 2022).
- Confirm whether the underwriters exercised the $15,000,000 option on the Senior Notes Offering.
- Review the attached press releases (Exhibits 99.1 and 99.2) for the specific intended use of proceeds from both offerings.
- Assess the impact of the new debt issuance on the company's total leverage and interest coverage ratios.